Cannon Gillian

Director at XENE

Sold, on record
$63k
Dollars the filings state
Form 4 sales
1
Latest Jun 5, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • XENEXenon Pharmaceuticals Inc.Director

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale XENERoutine
    Jun 5, 2026 2026

    Sold 1,190 shares at $53.14 ($63k)

    Cannon Gillian, Director

    10b5-1 planSold 45% of holdings ($141k position)1,455 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Cannon Gillian
Source
Jun 5, 2026Jun 8, 2026XENEDirectorForm 4 sale1,190$63k45.0%RoutineSEC